Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 101.20M | $ 80.60M | $ 92.50M | $ 62.20M | $ 51.40M |
Total Assets | $ 1.48B | $ 1.35B | $ 1.35B | $ 1.30B | $ 592.50M |
Total Debt | $ 76.00M | $ 90.70M | $ 98.70M | $ 99.10M | $ 89.30M |
Net Debt | $ -25.20M | $ 10.10M | $ 6.20M | $ 36.90M | $ 37.90M |
Total Liabilities | $ 334.60M | $ 335.90M | $ 336.30M | $ 292.90M | $ 183.60M |
Stockholders Equity | $ 1.14B | $ 1.01B | $ 1.01B | $ 1.00B | $ 408.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |